Monopar Therapeutics Inc · Other Income/Expenses (Net)

Latest reported$4.27Mperiod endingJun 30, 2026

MNPR TTM Other Income/Expenses (Net) ($8.03K → $4.27M)

TTM Other Income/Expenses (Net)

High-resolution chart · PNG

MNPR other income/expenses (net) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Monopar Therapeutics Inc Other Income/Expenses (Net) — Trailing twelve months (TTM) (USD)
Period ending	Other Income/Expenses (Net) (USD)
Jun 30, 2026	4,273,472
Mar 31, 2026	3,722,878
Dec 31, 2025	2,987,520
Sep 30, 2025	2,182,123
Jun 30, 2025	1,797,276
Mar 31, 2025	1,089,982
Dec 31, 2024	575,302
Sep 30, 2024	524,339
Jun 30, 2024	365,973
Mar 31, 2024	420,716
Dec 31, 2023	429,039
Sep 30, 2023	343,626
Jun 30, 2023	239,064
Mar 31, 2023	111,263
Dec 31, 2022	21,239
Sep 30, 2022	9,104
Jun 30, 2022	1,983
Mar 31, 2022	13,792
Dec 31, 2021	24,024
Sep 30, 2021	155,801
Jun 30, 2021	163,765
Mar 31, 2021	169,861
Dec 31, 2020	204,302
Sep 30, 2020	90,036
Jun 30, 2020	104,863
Mar 31, 2020	112,950
Dec 31, 2019	98,887
Sep 30, 2019	116,748
Jun 30, 2019	120,728
Mar 31, 2019	113,377
Dec 31, 2018	103,216
Sep 30, 2018	90,536
Jun 30, 2018	83,783
Mar 31, 2018	68,244
Dec 31, 2017	48,255
Sep 30, 2017	26,987
Jun 30, 2017	10,143
Mar 31, 2017	7,790
Dec 31, 2016	8,032